MDA Space Ltd. ("MDA Space" or the "Company") (TSX: MDA) (NYSE: MDA) today announced that, in connection with its recently completed marketed public offering (the "Offering") of common shares of...

H&M, Canaccord, GVR announce leadership appointments. By Azlina Ghazali October 27, 2026 Nisreen Balh has been appointed as the new head of expansion for real estate in Canada at the H&M Group. Balh, who previously worked as a project manager at H&M from 2016 to 2019, returns to the company with extensive experience in design, construction, and strategy. Her career includes roles at CHANEL, M Moser Associates, Gensler, Yum! Brands, and Progest Construction. Balh holds a master's degree in civil engineering from McGill University and a bachelor's in interior design from the Academy of Design. Leadership changes across Canadian firms. Veronica Jarvis has been named vice-president of investment banking real estate at Canaccord Genuity Global Capital Markets. Jarvis previously served as vice-president at Slate Asset Management for over six years and held positions in government, McMillan Vantage Policy Group, and Nanos Research. Craig Munn has been appointed interim chief executive officer of Greater Vancouver REALTORS (GVR) as of October 6. Munn brings nearly 20 years of experience with GVR, including roles as chief corporate development officer and vice-president of communication and events. Before joining GVR, he worked at the British Consulate General in Vancouver and as a reporter for community newspapers in B.C. Master Group and nesto recognize new leaders. Master Group, Canada's largest HVAC-R distributor, has named Rémy Langelier as president. Langelier, who recently led the company's enterprise transformation program, will succeed Louis St-Laurent as chief executive officer in the first quarter of 2027. St-Laurent will remain with the company in a mentoring role through December 2027. Malik Yacoubi, CEO and co-founder of nesto, a Montreal-based mortgage technology and financing provider, has been named the EY Entrepreneur Of The Year 2026 Eastern Overall Award winner. Yacoubi, with over 20 years of experience in building and scaling companies, founded nesto in 2018. RBC GAM expands private markets leadership. RBC Global Asset Management (GAM) has promoted Brandon Gill New to global head of private markets. Based in Toronto, Gill New will lead the firm's private market strategy and expand offerings in asset classes and geographies. She succeeds Michael Kitt, who transitioned to vice-chair at RBC GAM in 2023. Gill New brings over 25 years of global investment experience to the role. She previously served as managing director and head of external partnerships, public equities at Alberta Investment Management Company, one of Canada's largest pension funds. Before that, Gill New held increasingly senior roles at OPTrust, Ontario Teachers' Pension Plan Board, and BMO Capital Partners. Since 2019, RBC GAM's private markets solutions have grown to over $15 billion in client investments and it contributed towards achieving RBC's target of $1.1 trillion in assets under management by 2029. With these changes and appointments, Canadian firms continue to evolve and grow, driven by experienced leaders in their respective fields.

Sagility (NSE:SAGILITY): what does the Chirok Health acquisition mean for its provider strategy? You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to its research reports, in-depth technical and fundamental research. Learn More Sagility Limited (NSE:SAGILITY) filed a press release on 21 October 2026 disclosing the completed acquisition of Chirok Health, a US-based provider of Clinical Documentation Improvement, medical coding, and revenue integrity services, adding specialised mid-revenue cycle capabilities to Sagility's existing provider services platform. Key highlights. * Sagility has acquired Chirok Health, which was founded in 2020 and provides clinical documentation integrity, medical coding, audit and quality assurance, and revenue cycle optimisation services to US healthcare organisations. * The transaction follows Sagility's earlier acquisition of CareSeed, forming part of a stated strategy to build a comprehensive, end-to-end provider-focused services platform. * Canaccord Genuity LLC served as the exclusive financial adviser to Chirok Health on the transaction; the financial consideration was not disclosed in the exchange filing. * Chirok's specialised team of clinical documentation specialists, coding professionals, and auditors will join Sagility, expanding its clinical domain expertise across the US healthcare market. About the company. Sagility Limited (NSE:SAGILITY), formerly Sagility India Limited, is a Bengaluru-headquartered healthcare operations company focused exclusively on payers, providers, and pharmacy benefit managers in the United States. With over 25 years in healthcare, it delivers revenue cycle management, patient access, analytics, and AI-led operations across India, the US, the Philippines, Jamaica, and Colombia. Its CIN is L72900KA2021PLC150054. Announcement in detail. The exchange filing states that Sagility has completed the acquisition of Chirok Health, which supports healthcare organisations across fee-for-service and value-based care models. Chirok's services span Clinical Documentation Improvement, medical coding, coding quality assurance programs, and revenue integrity, described in the announcement as a natural complement to Sagility's existing front-end and back-end revenue cycle offerings. Ramesh Gopalan, Managing Director and Group CEO of Sagility, noted in the press release that Chirok's capabilities in CDI, medical coding, and quality assurance expand Sagility's ability to support providers across the healthcare value chain. Kanar Kokoy, Founder and CEO of Chirok Health, confirmed that clients will retain access to specialised expertise while gaining a broader capability set through the combined organisation. Impact on investors. Investors will note that the acquisition consideration has not been disclosed in the exchange filing, meaning the financial impact on Sagility's balance sheet, debt levels, or earnings per share cannot be assessed from the available announcement alone. The filing shows the deal has already closed, so it represents a completed transaction rather than a pending one subject to regulatory or shareholder approval. The disclosed terms indicate that the combination is intended to create cross-selling opportunities across both organisations' client bases and deepen Sagility's mid-revenue cycle capabilities, which the company describes as a strategic gap being addressed. Shareholders will observe that this is the second acquisition disclosed by the company within a stated provider growth strategy, following the earlier CareSeed transaction referenced in the press release. Sector / market context. The US healthcare revenue cycle management market has faced increasing complexity driven by the ongoing shift toward value-based care models, tightening reimbursement rules from government payers such as Medicare and Medicaid, and persistent clinical staffing shortages at hospitals and health systems. These dynamics have encouraged healthcare providers to outsource specialised functions including Clinical Documentation Improvement and coding quality assurance to third-party operators, expanding the addressable market for companies such as Sagility that combine domain expertise with technology-enabled delivery models. Unlock Premium Articles for Exclusive Insights! Disclaimer: The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. Kalkine Solutions Pvt. Ltd. do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. Kalkine Solutions Pvt. Ltd. is not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. Kalkine Solutions Pvt. Ltd. is not liable for any decisions made or actions taken based on the information provided on this website.